Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published o ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Dr. Bisher Mustafa of the Marshall Health Obesity Clinic in Huntington said there's a certain irony to waiting "until people have diabetes to start the medication." "The idea is to try to prevent ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...